Multi-tail hydrate inhibitors

US10059871B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-10059871-B2
Application numberUS-201715493778-A
CountryUS
Kind codeB2
Filing dateApr 21, 2017
Priority dateMay 5, 2014
Publication dateAug 28, 2018
Grant dateAug 28, 2018

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

Low-dosage hydrate inhibitor (“LDHI”) compounds comprising multiple lipophilic tails and a hydrophilic head may be employed into fluids to inhibit agglomeration of hydrates, among other things. Suitable hydrophilic heads may include quaternary or tertiary ammonium cation moieties, and combinations thereof. Such LDHI compounds in some embodiments may include reaction products of DETA and/or other amines, fatty acid(s), and, optionally, alkyl halide(s). Compounds according to some embodiments may be employed in fluids in various environments, such as a conduit penetrating a subterranean formation, or a conduit carrying fluid in an industrial setting.

First claim

Opening claim text (preview).

What is claimed is: 1. A method of inhibiting the formation of hydrate agglomerates, the method comprising: introducing a composition into a fluid comprising (i) water and (ii) one of gas, liquid hydrocarbon, and any combination thereof; wherein the composition comprises a low-dosage hydrate inhibitor (“LDHI”) compound comprising multiple lipophilic tails, a linking moiety, and an ammonium hydrophilic head comprising a quaternary ammonium cation moiety, and wherein the LDHI compound has the structural formula: wherein each of R 1 and R 2 is a C 1 to C 50 hydrocarbon chain; wherein each of Z and Z′ is a moiety comprising a functional group that comprises at least one carbon; wherein each of L and L′ is a C 1 to C 20 hydrocarbon chain; wherein each of R 3 and R 4 is independently selected from the group consisting of: hydrogen and a C 1 to C 10 hydrocarbon chain; and wherein R 3 R 4 N + is associated with an anion X − , wherein the X − comprises an anion selected from a group consisting of: a bromide, a carboxylate, an organic sulfonate, a hydroxide, and any combination thereof. 2. The method of claim 1 , wherein the composition is introduced in an amount such that the LDHI compound is present in the fluid in an amount equal to about 0.1 to about 3.0% volume based on water cut of the fluid. 3. The method of claim 2 , wherein the fluid resides within a conduit. 4. The method of claim 2 , wherein the fluid resides within a subterranean formation. 5. The method of claim 1 , wherein the fluid has a water cut of about 30% to about 50%. 6. The method of claim 1 , wherein the LDHI compound comprises the reaction product of a reaction between (i) an amide intermediate resulting from a reaction between diethylenetriamine (DETA) and one or more fatty acids; and (ii) alkyl halide. 7. The method of claim 6 , wherein the one or more fatty acids comprises a fatty acid selected from the group consisting of: corn oil, canola oil, and any combination thereof. 8. The method of claim 1 , wherein each lipophilic tail is independently a C 8 to C 18 hydrocarbon chain. 9. The method of claim 1 , wherein Z and Z′ are carbonyl groups, L and L′ are C 2 hydrocarbon chains, and the LDHI compound has the structural formula: 10. The method of claim 1 , wherein R 3 is a C 4 to C 8 hydrocarbon chain, and R 4 is hydrogen. 11. The method of claim 1 , wherein the fluid further comprises a solvent selected from the group consisting of: toluene, xylene, methanol, isopropyl alcohol, glycol, and combinations thereof.

Assignees

Inventors

Classifications

  • C09K8/52Primary

    Compositions for preventing, limiting or eliminating depositions, e.g. for cleaning · CPC title

  • Organic additives · CPC title

  • having the carbon atom of the carboxamide group bound to a hydrogen atom or to a carbon atom of an acyclic saturated carbon skeleton · CPC title

  • Hydrates inhibition by using well treatment fluids containing inhibitors of hydrate formers · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US10059871B2 cover?
Low-dosage hydrate inhibitor (“LDHI”) compounds comprising multiple lipophilic tails and a hydrophilic head may be employed into fluids to inhibit agglomeration of hydrates, among other things. Suitable hydrophilic heads may include quaternary or tertiary ammonium cation moieties, and combinations thereof. Such LDHI compounds in some embodiments may include reaction products of DETA and/or othe…
Who is the assignee on this patent?
Multi Chem Group Llc
What technology area does this patent fall under?
Primary CPC classification C09K8/52. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Aug 28 2018 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 1 related publication on this page (citations in our corpus or others sharing the same primary CPC).